Explore

Trendline Trendline
Kessler Topaz Meltzer Check, LLP Files Securities Fraud Lawsuit Against Soleno Therapeutics

Kessler Topaz Meltzer Check, LLP Files Securities Fraud Lawsuit Against Soleno Therapeutics

Kessler Topaz Meltzer Check, LLP Files Securities Fraud Lawsuit Against Soleno Therapeutics
Trendline Trendline
Rosen Law Firm Urges Inovio Pharmaceuticals Investors to Act Before April 7 Deadline in Class Action

Rosen Law Firm Urges Inovio Pharmaceuticals Investors to Act Before April 7 Deadline in Class Action

Rosen Law Firm Urges Inovio Pharmaceuticals Investors to Act Before April 7 Deadline in Class Action
Trendline Trendline
Faruqi Faruqi, LLP Alerts Ultragenyx Pharmaceutical Investors of Securities Class Action Deadline

Faruqi Faruqi, LLP Alerts Ultragenyx Pharmaceutical Investors of Securities Class Action Deadline

Faruqi Faruqi, LLP Alerts Ultragenyx Pharmaceutical Investors of Securities Class Action Deadline
Trendline Trendline
Rosen Law Firm Alerts Soleno Therapeutics Investors to Securities Fraud Lawsuit Deadline

Rosen Law Firm Alerts Soleno Therapeutics Investors to Securities Fraud Lawsuit Deadline

Rosen Law Firm Alerts Soleno Therapeutics Investors to Securities Fraud Lawsuit Deadline
Trendline Trendline
Rosen Law Firm Initiates Class Action Against Super Micro Computer for Export Control Violations

Rosen Law Firm Initiates Class Action Against Super Micro Computer for Export Control Violations

Rosen Law Firm Initiates Class Action Against Super Micro Computer for Export Control Violations
Trendline Trendline
Gemini Space Station Faces Class Action Lawsuit Over Securities Fraud Allegations

Gemini Space Station Faces Class Action Lawsuit Over Securities Fraud Allegations

Gemini Space Station Faces Class Action Lawsuit Over Securities Fraud Allegations
Trendline Trendline
monday.com Faces Securities Fraud Class Action Lawsuit with May Deadline

monday.com Faces Securities Fraud Class Action Lawsuit with May Deadline

monday.com Faces Securities Fraud Class Action Lawsuit with May Deadline
Trendline Trendline
Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Expanding into Metabolic Disorders

Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Expanding into Metabolic Disorders

Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Expanding into Metabolic Disorders
Trendline Trendline
Rosen Law Firm Urges Corcept Therapeutics Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Corcept Therapeutics Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Corcept Therapeutics Investors to Act Before Class Action Deadline
Trendline Trendline
Soleno Therapeutics Faces Securities Fraud Lawsuit Led by Rosen Law Firm

Soleno Therapeutics Faces Securities Fraud Lawsuit Led by Rosen Law Firm

Soleno Therapeutics Faces Securities Fraud Lawsuit Led by Rosen Law Firm
Trendline Trendline
Kessler Topaz Meltzer Check, LLP Alerts Soleno Therapeutics Investors to Securities Fraud Class Action

Kessler Topaz Meltzer Check, LLP Alerts Soleno Therapeutics Investors to Securities Fraud Class Action

Kessler Topaz Meltzer Check, LLP Alerts Soleno Therapeutics Investors to Securities Fraud Class Action
Trendline Trendline
Rosen Law Firm Initiates Class Action Against Pinterest for Misleading Investors

Rosen Law Firm Initiates Class Action Against Pinterest for Misleading Investors

Rosen Law Firm Initiates Class Action Against Pinterest for Misleading Investors